Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Peter Singleton who wrote (5111)	8/12/1998 3:59:00 AM
From: Intel Trader	Read Replies (2) \| Respond to of 6136

Hi folks, it is early in the morning here, and truthfully, I'm not sleeping too well tonight. Although things seem a bit bearish, here are my 2 cents: Agouron is at a relatively low point, along with the rest of the market. Agouron's recent price decline I suspect is due in part to general conditions. I think that we are at a base of sorts, and that things will turn up soon that will take the Dow to 9500 and beyond. Why do I say this? Current interest rates are the peg that justifies the higher price/earnings multiples the market has attained. In the near term, it is my opinion that we are at a market inflexion point (ie the trough in the short term). All negative factors have essentially maxed out (whether they are totally maxed is another story). If you can hang in there through the end of next week we should see improvements in the general hue of the landscape. I wouldn't do anything drastic if I were the little guy (and like many of you, I am), but do do what makes you comfortable in your investment decisions. Hang in there, it